China's New Drug Price Policies Will Favor Big Distributors, Restrict Smaller Ones
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China is releasing a series of new policies to fight bribery in the pharmaceutical industry and reduce drug prices, which will benefit large distributors such as SinoPharm, Shanghai Pharmaceutical Group and Jointown, said an expert in a Citi research conference call July 19